Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 59
Filtrar
1.
Foods ; 13(4)2024 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-38397514

RESUMEN

Scale gelatin films derived from croaker fish and infused with Prosopis (Prosopis cineraria) extract (PE) at concentrations of 0.3% and 0.7% were produced. A control film, void of extract, was employed for comparative purposes. The thickness of each film was found to be statistically insignificant (p > 0.05). The results show that the highest solubility (78.57 ± 3.57%) was found for the glycerol film, and the least permeability was found for the water vapor (0.74 ± 0.09 ×10-10g s-1m-1Pa-1); however, the water vapor permeability (WVP) and water solubility (WS) of the films that contained PE were considerably lower than those of the control film (p < 0.05). In contrast to the control film, those infused with 0.7% PE exhibited exceptional UV-barrier properties (>99%) and favorable thermal characteristics. The highest and lowest antioxidant activities were found for the 7% Prosopis cineraria extract (56.96 ± 2.6%) and the glycerol film (40.66 ± 2.46%), respectively. No antibacterial activity was observed in these films. Microscopic pictures showed that all three films had a uniform and plain surface. Fourier transform infrared spectroscopy-attenuated total reflectance (FTIR-ATR) analysis revealed distinct amide bands and protein-polyphenol interactions within the films that contained the extract.

2.
Phys Med Biol ; 69(4)2024 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-38286017

RESUMEN

Objective. Gold nanorods (GNRs) have emerged as versatile nanoparticles with unique properties, holding promise in various modalities of cancer treatment through drug delivery and photothermal therapy. In the rapidly evolving field of nanoparticle radiosensitization (NPRS) for cancer therapy, this study assessed the potential of gold nanorods as radiosensitizing agents by quantifying the key features of NPRS, such as secondary electron emission and dose enhancement, using Monte Carlo simulations.Approach. Employing the TOPAS track structure code, we conducted a comprehensive evaluation of the radiosensitization behavior of spherical gold nanoparticles and gold nanorods. We systematically explored the impact of nanorod geometry (in particular size and aspect ratio) and orientation on secondary electron emission and deposited energy ratio, providing validated results against previously published simulations.Main results. Our findings demonstrate that gold nanorods exhibit comparable secondary electron emission to their spherical counterparts. Notably, nanorods with smaller surface-area-to-volume ratios (SA:V) and alignment with the incident photon beam proved to be more efficient radiosensitizing agents, showing superiority in emitted electron fluence. However, in the microscale, the deposited energy ratio (DER) was not markedly influenced by the SA:V of the nanorod. Additionally, our findings revealed that the geometry of gold nanoparticles has a more significant impact on the emission of M-shell Auger electrons (with energies below 3.5 keV) than on higher-energy electrons.Significance. This research investigated the radiosensitization properties of gold nanorods, positioning them as promising alternatives to the more conventionally studied spherical gold nanoparticles in the context of cancer research. With increasing interest in multimodal cancer therapy, our findings have the potential to contribute valuable insights into the perspective of gold nanorods as effective multipurpose agents for synergistic photothermal therapy and radiotherapy. Future directions may involve exploring alternative metallic nanorods as well as further optimizing the geometry and coating materials, opening new possibilities for more effective cancer treatments.


Asunto(s)
Nanopartículas del Metal , Nanotubos , Fármacos Sensibilizantes a Radiaciones , Oro/farmacología , Oro/química , Nanopartículas del Metal/química , Fármacos Sensibilizantes a Radiaciones/farmacología , Fármacos Sensibilizantes a Radiaciones/química , Simulación por Computador
3.
Gene ; 896: 148030, 2024 Feb 20.
Artículo en Inglés | MEDLINE | ID: mdl-38008270

RESUMEN

Sistan Yaghooti grape variety, despite characteristics such as early ripening, is vulnerable to cluster rot due to small berries and dense clusters. In this regard, AS may serve as a regulatory mechanism during developmental processes and in response to environmental signals. RNA-Seq analysis was performed to measure gene expression and the extent of AS events in the cluster growth and development stages of Sistan Yaghooti grape. The number of AS events increased during stages, suggesting that it contributes to the grapevine's adaptability to various stresses. In addition, DEG and DAS genes showed little overlap in cluster growth stages. Functional analysis of 19,194 DAS -gene sets showed that VIT_06s0004g06670 gene is involved in the activation of calcium channels (Ca2+) through the activation of 5 PLC biosynthetic pathways. Among the 27,229 DEG -sets, VIT_07s0005g05320 gene showed higher expression. Interestingly, this gene is involved in the synthesis of an EF -hand domain-containing protein capable of binding to Ca2+ by activating 4 biochemical pathways. These genes increase cytosolic Ca2+ concentration, enhancing plant stress tolerance and resistance to cracking. These results show that AS can respond independently to different types of stress. Among the other DAS genes, the GA2ox gene (VvGA2ox) showed an increase in AS events during cluster development. This gene is critical for initiating the degradation process of GA and plays a crucial role in different stages of seed development. Therefore, it is very likely that this gene is one of the main factors responsible for the density and seedlessness of Sistan Yaghooti grape.


Asunto(s)
Vitis , Vitis/genética , Empalme Alternativo , Perfilación de la Expresión Génica , RNA-Seq , Frutas , Crecimiento y Desarrollo , Regulación de la Expresión Génica de las Plantas
4.
J Control Release ; 363: 507-524, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37797891

RESUMEN

Many viruses, bacteria, and parasites rely on the lymphatic system for survival, replication, and dissemination. While conventional anti-infectives can combat infection-causing agents in the bloodstream, they do not reach the lymphatic system to eradicate the pathogens harboured there. This can result in ineffective drug exposure and reduce treatment effectiveness. By developing effective lymphatic delivery strategies for antiviral, antibacterial, and antiparasitic drugs, their systemic pharmacokinetics may be improved, as would their ability to reach their target pathogens within the lymphatics, thereby improving clinical outcomes in a variety of acute and chronic infections with lymphatic involvement (e.g., acquired immunodeficiency syndrome, tuberculosis, and filariasis). Here, we discuss approaches to targeting anti-infective drugs to the intestinal and dermal lymphatics, aiming to eliminate pathogen reservoirs and interfere with their survival and reproduction inside the lymphatic system. These include optimized lipophilic prodrugs and drug delivery systems that promote lymphatic transport after oral and dermal drug intake. For intestinal lymphatic delivery via the chylomicron pathway, molecules should have logP values >5 and long-chain triglyceride solubilities >50 mg/g, and for dermal lymphatic delivery via interstitial lymphatic drainage, nanoparticle formulations with particle size between 10 and 100 nm are generally preferred. Insight from this review may promote new and improved therapeutic solutions for pathogen eradication and combating infective diseases, as lymphatic system involvement in pathogen dissemination and drug resistance has been neglected compared to other pathways leading to treatment failure.


Asunto(s)
Vasos Linfáticos , Profármacos , Sistemas de Liberación de Medicamentos , Vasos Linfáticos/metabolismo , Sistema Linfático/metabolismo , Intestinos
5.
Front Plant Sci ; 14: 1156665, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37502707

RESUMEN

The commercialization of GE crops requires a rigorous safety assessment, which includes a precise DNA level characterization of inserted T-DNA. In the past, several strategies have been developed for identifying T-DNA insertion sites including, Southern blot and different PCR-based methods. However, these methods are often challenging to scale up for screening of dozens of transgenic events and for crops with complex genomes, like potato. Here, we report using target capture sequencing (TCS) to characterize the T-DNA structure and insertion sites of 34 transgenic events in potato. This T-DNA is an 18 kb fragment between left and right borders and carries three resistance (R) genes (RB, Rpi-blb2 and Rpi-vnt1.1 genes) that result in complete resistance to late blight disease. Using TCS, we obtained a high sequence read coverage within the T-DNA and junction regions. We identified the T-DNA breakpoints on either ends for 85% of the transgenic events. About 74% of the transgenic events had their T-DNA with 3R gene sequences intact. The flanking sequences of the T-DNA were from the potato genome for half of the transgenic events, and about a third (11) of the transgenic events have a single T-DNA insertion mapped into the potato genome, of which five events do not interrupt an existing potato gene. The TCS results were confirmed using PCR and Sanger sequencing for 6 of the best transgenic events representing 20% of the transgenic events suitable for regulatory approval. These results demonstrate the wide applicability of TCS for the precise T-DNA insertion characterization in transgenic crops.

6.
Rev Sci Instrum ; 94(2): 023308, 2023 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-36859068

RESUMEN

High-resolution photon-counting detector (PCD) computed tomography (CT) imaging is increasingly used for several applications. Recent technological advances in CT instrumentation have introduced various types of radiation detectors. Therefore, this work aims at evaluating the lutetium-yttrium oxyorthosilicate (LYSO) scintillator for use in PCD CT from a detector point of view. To do so, a mini-CT prototype was designed and constructed based on the pixelated LYSO blocks. The detector comprises four 10 × 10 linearly arranged LYSO blocks coupled with four position-sensitive photomultiplier tubes. The prototype utilizes a point gamma-ray source along with a cone-beam collimator. An in-home MATLAB-based data processing software package was also developed for storing the list-mode data, event positioning, and energy windowing. A set of experiments were conducted to assess the performance of the constructed energy-resolved LYSO:Ce detector for mini-CT imaging. The results show good crystal identification for all blocks with a maximum peak-to-valley ratio of 3.48. In addition, the findings confirm that the developed detector is position-sensitive. The 20% energy window provides an optimal performance by simultaneously providing good crystal identification and a scatter removal factor of 0.71. A 96% uniformity was also observed when the detector was irradiated with a uniform flood. The spatial resolution of the mini-CT prototype in the x- and y-directions was calculated to be 0.9 and 0.93 mm, respectively, corrected for a magnification factor of 2.5. It is concluded that the pixelated LYSO crystal is a promising alternative to the current detectors and would be the scintillator of choice for high-resolution PCD CT imaging tasks.

7.
BMC Biotechnol ; 23(1): 2, 2023 01 24.
Artículo en Inglés | MEDLINE | ID: mdl-36694155

RESUMEN

BACKGROUND: Rhamnolipids are a group of the extracellular microbial surface-active molecules produced by certain Pseudomonas species with various environmental and industrial applications. The goal of the present research was to identify and optimize key process parameters for Pseudomonas aeruginosa PTCC 1074s synthesis of rhamnolipids utilizing soybean meal in solid state fermentation. A fractional factorial design was used to screen the key nutritional and environmental parameters to achieve the high rhamnolipid production. Response surface methodology was used to optimize the levels of four significant factors. RESULTS: The characterization of biosurfactant by TLC, FT-IR and H-NMR showed the rhamnolipids presence. In the optimum conditions (temperature 34.5 °C, humidity 80%, inoculum size 1.4 mL, and glycerol 5%), the experimental value of rhamnolipid production was 19.68 g/kg dry substrate. The obtained rhamnolipid biosurfactant decreased water's surface tension from 71.8 ± 0.4 to 32.2 ± 0.2 mN/m with a critical micelle concentration of nearly 70 mg/L. Additionally, analysis of the emulsification activity revealed that the generated biosurfactant was stable throughout a broad pH, temperature, and NaCl concentration range. CONCLUSIONS: The current study confirmed the considerable potential of agro-industrial residues in the production of rhamnolipid and enhanced the production yield by screening and optimizing the significant process parameters.


Asunto(s)
Pseudomonas aeruginosa , Tensoactivos , Fermentación , Espectroscopía Infrarroja por Transformada de Fourier , Tensoactivos/química , Glucolípidos/química
8.
Clin Microbiol Infect ; 29(2): 215-220, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36096430

RESUMEN

OBJECTIVES: We sought to investigate the efficacy and safety of SpikoGen®, a subunit coronavirus disease 2019 (COVID-19) vaccine composed of a recombinant severe acute respiratory syndrome coronavirus 2 spike protein with Advax-CpG55.2™ adjuvant. METHODS: This randomized, placebo-controlled, double-blind, phase 3 trial was conducted on 16 876 participants randomized (3:1) to receive two intramuscular doses of SpikoGen® or a saline placebo 21 days apart. The primary outcome was to assess the efficacy of SpikoGen® in preventing symptomatic COVID-19. Secondary outcomes included safety assessments and evaluation of SpikoGen® vaccine's efficacy in preventing severe COVID-19. The study aimed for 147 COVID-19 symptomatic cases. RESULTS: Overall, 12 657 and 4219 participants were randomized to the SpikoGen® and placebo group and followed for a median of 55 days (interquartile range, 48-60 days) and 51 days (interquartile range, 46-58 days) after 14 days of the second dose, respectively. In the final per-protocol analysis, the number of COVID-19 cases was 247 of 9998 (2.4%) in the SpikoGen® group and 119 of 3069 (3.8%) in the placebo group. This equated to a vaccine efficacy of 43.99% (95% CI, 30.3-55.0%). The efficacy was calculated to be 44.22% (95% CI, 31.13-54.82%) among all participants who received both doses. From 2 weeks after the second dose, 5 of 9998 (0.05%) participants in the SpikoGen® group and 6 of 3069 (0.19%) participants in the placebo group developed severe COVID-19, equating to a vaccine efficacy against severe disease of 77.51% (95% CI, 26.3-93.1%). The SpikoGen® vaccine was well tolerated. DISCUSSION: A 2-dose regimen of SpikoGen® reduced the rate of COVID-19 and severe disease in the wave of the Delta variant.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , SARS-CoV-2 , Glicoproteína de la Espiga del Coronavirus , Humanos , Anticuerpos Antivirales , COVID-19/prevención & control , Vacunas contra la COVID-19/uso terapéutico , Método Doble Ciego
9.
Expert Rev Clin Pharmacol ; 15(6): 767-777, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35579011

RESUMEN

OBJECTIVES: Performing an updated meta-analysis to compare the safety and efficacy of insulin glargine and insulin detemir in adults with type 1 and type 2 diabetes. METHODS: Electronic databases were searched up to 18 August 2021. A random-effects model was applied to pool data from included studies to calculate the standardized mean differences (SMDs) for the continuous variables and relative risks (RRs) for the dichotomous variable. RESULTS: Nine studies compared insulin detemir and insulin glargine in type 2 diabetes and three studies in patients with type 1 diabetes. The pooled SMD of weight gain was -0.59 (95% CI -1.05 to -0.14; P=0.01; I2=98%) in patients with type 2 diabetes. The pooled RR of severe hypoglycemia was 0.28 (95% CI 0.12 to 0.63; P=0.002; I2=0%) in patients with type 1 diabetes. The effects of detemir and glargine on HbA1c, fasting plasma glucose, nocturnal hypoglycemia, and overall hypoglycemia were not statistically different (P>0.05). CONCLUSIONS: It was found that there is no clinically considerable difference between the impacts of insulin detemir and insulin glargine in diabetic patients. The only statistically significant differences were less weight gain in type 2 diabetes and fewer episodes of severe hypoglycemia in type 1 diabetes with insulin detemir.


Asunto(s)
Diabetes Mellitus Tipo 1 , Diabetes Mellitus Tipo 2 , Hipoglucemia , Adulto , Glucemia , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hemoglobina Glucada , Humanos , Hipoglucemia/inducido químicamente , Hipoglucemiantes/efectos adversos , Insulina , Insulina Detemir/efectos adversos , Insulina Glargina/efectos adversos , Insulina de Acción Prolongada/efectos adversos , Aumento de Peso
10.
Clin Microbiol Infect ; 28(9): 1263-1271, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35436611

RESUMEN

OBJECTIVE: We aimed to investigate the immunogenicity and safety of SpikoGen®, a subunit COVID-19 vaccine composed of a recombinant prefusion-stabilized SARS-CoV-2 spike protein combined with the Advax-CpG55.2™ adjuvant, in seronegative and seropositive populations as primary vaccination. METHODS: This randomized, placebo-controlled, double-blind phase 2 trial was conducted on 400 participants randomized 3:1 to receive two doses of 25 µg of SpikoGen® 3 weeks apart or the placebo. The primary safety outcomes were the incidence of solicited adverse events up to 7 days after each dose and unsolicited adverse events up to 28 days after the second dose. The primary immunogenicity outcomes were seroconversion against the S1 protein and the geometric mean concentration of S1 antibodies by days 21 and 35. RESULTS: The SpikoGen® vaccine was well tolerated and no serious adverse events were recorded. The most common solicited adverse events were injection site pain and fatigue, largely graded as mild and transient. By day 35 (2 weeks post second dose), the seroconversion rate against S1 was 63.55 (95% CI: 57.81-69.01) in the SpikoGen® group versus 7.23 (95% CI: 2.7-15.07) in the placebo group. The geometric mean concentration of S1 antibodies was 29.12 (95% CI: 24.32-34.87) in the SpikoGen® group versus 5.53 (95% CI: 4.39-6.97) in the placebo group. Previously infected seropositive volunteers showed a large SARS-CoV-2 humoral response after a single SpikoGen® dose. DISCUSSION: SpikoGen® had an acceptable safety profile and induced promising humoral and cellular immune responses against SARS-CoV-2.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Anticuerpos Neutralizantes , Anticuerpos Antivirales , COVID-19/prevención & control , Vacunas contra la COVID-19/efectos adversos , Método Doble Ciego , Humanos , Inulina/análogos & derivados , SARS-CoV-2 , Glicoproteína de la Espiga del Coronavirus , Vacunas de Subunidad
11.
BMC Surg ; 22(1): 26, 2022 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-35081942

RESUMEN

BACKGROUND AND OBJECTIVE: We report our experiences with Intraoperative radiation therapy (IORT) among breast cancer (BC) patients in our region. METHODS: All patients who received radical IORT from April 2014 on to March 2020 were included in the study. Patient selection criteria included: Age equal or older than 45 years old; All cases of invasive carcinomas (in cases of lobular carcinomas only with MRI and confirmation); Patients who were 45-50 years old with a tumor size of 0-2 cm, 50-55 years old with a tumor size of < 2.5 cm, and those who were ≥ 55 years old with a tumor size of < 3 cm; Invasive tumors only with a negative margin; Negative nodal status (exception in patients with micrometastasis); A positive estrogen receptor status. Primary endpoints included death and recurrence which were assessed using the Kaplan-Meier method. RESULTS: Overall, 252 patients entered the study. Mean (SD) age of patients was 56.43 ± 7.79 years. In total, 32.9% of patients had a family history of BC. Mean (SD) tumor size was 1.56 ± 0.55 cm. Mean (IQR) follow-up of patients was 36.3 ± 18.7 months. Overall, 8 patients (3.1%) experienced recurrence in follow-up visits (disease-free-survival of 96.1%), among which four (1.5%) were local recurrence, two (0.8%) were regional recurrence and two patients (0.8%) had metastasis. Median (IQR) time to recurrence was 46 (22, 53.7) months among the eight patient who had recurrence. Overall, one patient died due to metastasis in our series. Eleven patients (4.3%) with DCIS in our study received IORT. All these patients had free margins in histopathology examination and none experienced recurrence. CONCLUSION: Inhere we reported our experience with the use of IORT in a region where facilities for IORT are limited using our modified criteria for patient selection.


Asunto(s)
Neoplasias de la Mama , Neoplasias de la Mama/radioterapia , Neoplasias de la Mama/cirugía , Terapia Combinada , Supervivencia sin Enfermedad , Femenino , Humanos , Cuidados Intraoperatorios , Mastectomía Segmentaria , Persona de Mediana Edad , Recurrencia Local de Neoplasia/epidemiología
12.
Sci Rep ; 11(1): 23964, 2021 12 14.
Artículo en Inglés | MEDLINE | ID: mdl-34907242

RESUMEN

Successful delivery of plasmid DNA into the microbial cells is fundamental in recombinant DNA technology. Natural bacterial transformation is limited to only certain species due in part to the repulsive forces between negatively charged DNA and bacterial membranes. Most common method of DNA delivery into bacteria is artificial transformation through heat shock and electroporation. These methods require sophisticated instruments and tedious steps in preparation of competent cells. Transformation by conjugation is also not applicable to all plasmids. Nanoparticles have been used successfully in therapeutics for drug delivery into animal cells. They are starting to gain popularity in plant sciences as novel DNA nano carriers. Despite their promise as tool for DNA delivery, their use in microbial cell transformation has not been reported yet. Here we report the synthesis of carbon dots (CDs) from citric acid and ß-alanine and their use in DNA delivery into E. coli cells. CDs were fabricated using microwave assisted synthesis. Plasmids carrying RFP reporter and ampicillin resistance genes were transferred to bacterial cells and further confirmed using polymerase chain reaction. Our findings indicate that CDs can be used successfully for delivery of foreign DNA of up to 10 kb into E. coli. We have demonstrated the use of ß-alanine/citric acid carbon dots as nanocarriers of DNA into E. coli cells and identified their limitation in terms of the size of plasmid DNA they could carry. Use of these carbon dots is a novel method in foreign DNA delivery into bacterial cells and have a potential for the transformation of resistant organism for which there is still no reliable DNA delivery systems.


Asunto(s)
Ácido Cítrico/química , ADN , Escherichia coli/genética , Nanoestructuras/química , Plásmidos , Transformación Bacteriana , beta-Alanina/química , ADN/química , ADN/genética , Plásmidos/química , Plásmidos/genética
13.
Plants (Basel) ; 10(9)2021 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-34579504

RESUMEN

Bacterial wilt (BW) caused by the Gram-negative bacterium, Erwinia tracheiphila (Et.), is an important disease in melon (Cucumis melo L.). BW-resistant commercial melon varieties are not widely available. There are also no effective pathogen-based disease management strategies as BW-infected plants ultimately die. The purpose of this study is to identify BW-resistant melon accessions in the United States Department of Agriculture (USDA) collection. We tested 118 melon accessions in two inoculation trials under controlled environments. Four-week-old seedlings of test materials were mechanically inoculated with the fluorescently (GFP) labeled or unlabeled E. tracheiphila strain, Hca1-5N. We recorded the number of days to wilting of inoculated leaf (DWIL), days to wilting of whole plant (DWWP) and days to death of the plant (DDP). We identified four melon lines with high resistance to BW inoculation based on all three parameters. Fluorescent microscopy was used to visualize the host colonization dynamics of labeled bacteria from the point of inoculation into petioles, stem and roots in resistant and susceptible melon accessions, which provides an insight into possible mechanisms of BW resistance in melon. The resistant melon lines identified from this study could be valuable resistance sources for breeding of BW resistance as well as the study of cucurbit-E. tracheiphila interactions.

14.
Nanomaterials (Basel) ; 11(8)2021 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-34443843

RESUMEN

While multi-drug resistance in bacteria is an emerging concern in public health, using carbon dots (CDs) as a new source of antimicrobial activity is gaining popularity due to their antimicrobial and non-toxic properties. Here we prepared carbon dots from citric acid and ß-alanine and demonstrated their ability to inhibit the growth of diverse groups of Gram-negative bacteria, including E. coli, Salmonella, Pseudomonas, Agrobacterium, and Pectobacterium species. Carbon dots were prepared using a one-pot, three-minute synthesis process in a commercial microwave oven (700 W). The antibacterial activity of these CDs was studied using the well-diffusion method, and their minimal inhibitory concentration was determined by exposing bacterial cells for 20 h to different concentrations of CDs ranging from 0.5 to 10 mg/mL. Our finding indicates that these CDs can be an effective alternative to commercially available antibiotics. We also demonstrated the minimum incubation time required for complete inhibition of bacterial growth, which varied depending on bacterial species. With 15-min incubation time, A. tumefaciens and P. aeruginosa were the most sensitive strains, whereas E. coli and S. enterica were the most resistant bacterial strains requiring over 20 h incubation with CDs.

15.
Biomed Res Int ; 2021: 5535562, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33997001

RESUMEN

PURPOSE: Sepsis originates from the host inflammatory response, especially to bacterial infections, and is considered one of the main causes of death in intensive care units. Various agents have been developed to inhibit mediators of the inflammatory response; one prospective agent is ß-sitosterol (ßS), a phytosterol with a structure similar to cholesterol. This study is aimed at evaluating the effects of ßS on the biomarkers of inflammation and liver function in cecal ligation and puncture- (CLP-) induced septic rats. METHODS: Thirty male Wistar rats were divided equally into six groups as follows: sham, CLP, CLP+dexamethasone (DX, 0.2 mg/kg), CLP+ßS (1 mg/kg), CLP+imipenem (IMI, 20 mg/kg), and CLP+IMI (20 mg/kg)+ßS (1 mg/kg). Serum levels of IL-1ß, IL-6, IL-10, AST, ALT, and liver glutathione (GSH) were assessed by ELISA. Liver expression levels of TNF-α and NF-κBi mRNAs were evaluated by RT-qPCR. RESULTS: Serum concentrations of IL-1ß, IL-6, IL-10, ALT, and AST and mRNA levels of TNF-α and NF-κBi were all significantly higher in septic rats than in normal rats (p < 0.05). Liver GSH content was markedly lower in the CLP group than that in the sham group. ßS-treated rats had remarkably lower levels of IL-1ß, IL-6, IL-10, TNF-α, NF-κBi, AST, and ALT (51.79%, 62.63%, 41.46%, 54.35%, 94.37%, 95.30%, 34.87%, and 46.53% lower, respectively) and greater liver GSH content (35.71% greater) compared to the CLP group (p < 0.05). CONCLUSION: ßS may play a protective role in the septic process by mitigating inflammation. This effect is at least partly mediated by inhibition of the NF-κB signaling pathway. Thus, ßS can be considered as a supplementary treatment in septic patients.


Asunto(s)
Inflamación/metabolismo , Hígado , FN-kappa B/metabolismo , Sepsis , Sitoesteroles/farmacología , Animales , Antiinflamatorios/farmacología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Hígado/química , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratas , Ratas Wistar , Sepsis/metabolismo , Sepsis/mortalidad , Transducción de Señal/efectos de los fármacos
16.
Expert Rev Clin Immunol ; 17(5): 499-511, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33823733

RESUMEN

OBJECTIVES: Currently published papers and clinical guidelines regarding the effects of tocilizumab in severe and critical COVID-19 are contradictory. The aim of this meta-analysis was to combine the results of clinical studies of different designs to investigate the efficacy and safety of tocilizumab in severely-to-critically ill COVID-19 patients. METHODS: A systematic search was performed in PubMed, Embase, CENTRAL, ClinicalTrials.gov, Scopus, and preprint servers up to 26 December 2020. Since a substantial heterogeneity was expected, a random-effects model was applied to calculate the pooled effect size (ES) and 95% confidence interval (CI) for each study outcome. RESULTS: Forty-five comparative studies involving 13,189 patients and 28 single-arm studies involving 1,770 patients were analyzed. The risk of mortality (RR of 0.76 [95%CI 0.65 to 0.89], P < 0.01) and intubation (RR of 0.48 [95%CI 0.24 to 0.97], P = 0.04) were lower in tocilizumab patients compared with controls. We did not find any significant difference in secondary infections, length of hospital stay, hospital discharge before day 14, and ICU admission between groups. CONCLUSION: Tocilizumab can improve clinical outcomes and reduce mortality rates in severe to critical COVID-19 patients. Large-scale randomized controlled trials are still required to improve the statistical power of meta-analysis.


Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Tratamiento Farmacológico de COVID-19 , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Anticuerpos Monoclonales Humanizados/efectos adversos , Humanos
17.
Appl Radiat Isot ; 172: 109667, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33711587

RESUMEN

Measuring the wax deposition inside pipelines is one of the critical parameters in the oil, gas and petrochemical industries to control the flow through the pipelines. This paper presents a novel method using artificial neural networks to measure the thickness of the wax. This method was based on counting the backscattered gamma-ray from different thicknesses of the wax inside the pipes with different diameters. For this purpose, the system was simulated by MCNPX code and the designed setup was optimized. The main analyses were based on the simulation results but the verification was performed using a real experimental setup. The results showed a good agreement between the simulation results and the experimental data with a root mean square error less than 1%. Response of the detector was simulated for a standard industrial nominal pipe ranged from 2 to 4.5 inches and for radiation sources 137Cs and 60Co. Using these data, a multilayer perceptron for different energy sources was trained. The best prediction of the wax thickness was obtained for the case of using two radiation sources, simultaneously. The output of the trained neural network showed that the proposed method is capable of measuring the wax thickness inside the pipe with a good accuracy.

18.
Int Immunopharmacol ; 95: 107522, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33735712

RESUMEN

BACKGROUND: We examined the safety and efficacy of a treatment protocol containing Favipiravir for the treatment of SARS-CoV-2. METHODS: We did a multicenter randomized open-labeled clinical trial on moderate to severe cases infections of SARS-CoV-2. Patients with typical ground glass appearance on chest computerized tomography scan (CT scan) and oxygen saturation (SpO2) of less than 93% were enrolled. They were randomly allocated into Favipiravir (1.6 gr loading, 1.8 gr daily) and Lopinavir/Ritonavir (800/200 mg daily) treatment regimens in addition to standard care. In-hospital mortality, ICU admission, intubation, time to clinical recovery, changes in daily SpO2 after 5 min discontinuation of supplemental oxygen, and length of hospital stay were quantified and compared in the two groups. RESULTS: 380 patients were randomly allocated into Favipiravir (193) and Lopinavir/Ritonavir (187) groups in 13 centers. The number of deaths, intubations, and ICU admissions were not significantly different (26, 27, 31 and 21, 17, 25 respectively). Mean hospital stay was also not different (7.9 days [SD = 6] in the Favipiravir and 8.1 [SD = 6.5] days in Lopinavir/Ritonavir groups) (p = 0.61). Time to clinical recovery in the Favipiravir group was similar to Lopinavir/Ritonavir group (HR = 0.94, 95% CI 0.75 - 1.17) and likewise the changes in the daily SpO2 after discontinuation of supplemental oxygen (p = 0.46) CONCLUSION: Adding Favipiravir to the treatment protocol did not reduce the number of ICU admissions or intubations or In-hospital mortality compared to Lopinavir/Ritonavir regimen. It also did not shorten time to clinical recovery and length of hospital stay.


Asunto(s)
Amidas/administración & dosificación , Amidas/efectos adversos , Antivirales/administración & dosificación , Antivirales/efectos adversos , Tratamiento Farmacológico de COVID-19 , Pirazinas/administración & dosificación , Pirazinas/efectos adversos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Quimioterapia Combinada , Femenino , Humanos , Hidroxicloroquina/administración & dosificación , Hidroxicloroquina/efectos adversos , Intubación , Estimación de Kaplan-Meier , Tiempo de Internación , Lopinavir/administración & dosificación , Lopinavir/efectos adversos , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Ritonavir/administración & dosificación , Ritonavir/efectos adversos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Adulto Joven
19.
Ann Work Expo Health ; 65(3): 346-357, 2021 04 22.
Artículo en Inglés | MEDLINE | ID: mdl-33095851

RESUMEN

Respirable crystalline silica (RCS) overexposure can lead to the development of silicosis which is a chronic, irreversible, potentially fatal respiratory disease. The most significant prerequisite for any silica exposure control plan is an accurate occupational exposure assessment. The results of crystalline silica analysis are often affected by other mineral interferences and are influenced by an analyst's knowledge of mineralogy to accurately interpret infrared spectra and correct matrix interferences. Partial least squares (PLS) and artificial neural networks (ANNs) are two multivariate calibration methods to overcome the problem of spectral interferences without the need for an analyst intervention. The performance of these two methods in quantitative analysis of quartz in the presence of mineral interferences was evaluated and compared in this study. Fifty mixtures with different crystalline silica content ratios were prepared by mixing quartz with four common mineral interferences including kaolinite, albite, muscovite, and amorphous silica. Fourier-transform infrared spectra of the mixtures were split into training and test datasets. The optimal architecture of the ANN model was achieved using a two-level full factorial design experiment and data were modeled using ANN and PLS regression analysis. Root mean squared error of prediction values of 1.69 and 6.12 µg quartz for ANN and PLS models, respectively, revealed the fact that the both models performed very well in quantitative analysis of quartz in the presence of mineral interferences, with a better relative performance of the ANN model which can be related to the inherent nonlinear predictive ability of ANNs. Given the excellent predictive ability of the ANN model which can deal with a completely overlapped peak without any need of user's intervention, it is recommended that the ANN model be optimized in future studies and utilized for reliable and rapid on-field assessment of RCS exposure.


Asunto(s)
Exposición Profesional , Humanos , Análisis de los Mínimos Cuadrados , Redes Neurales de la Computación , Exposición Profesional/análisis , Dióxido de Silicio/análisis , Espectroscopía Infrarroja por Transformada de Fourier
20.
Emerg Infect Dis ; 26(8): 1954-1956, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32687045

RESUMEN

We detected Heartland virus (HRTV) in lone star nymphs collected in 2018 in northern Alabama, USA. Real-time reverse transcription PCR selective for the small segment of the HRTV genome and confirmatory sequencing of positive samples showed high identity with HRTV strains sequenced from Tennessee and Missouri.


Asunto(s)
Ixodidae , Phlebovirus , Alabama/epidemiología , Amblyomma , Animales , Missouri/epidemiología , Tennessee
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA